NASDAQ: CMMB
Chemomab Therapeutics Ltd Stock Ownership - Who owns Chemomab Therapeutics?

Insider buying vs selling

Have Chemomab Therapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CMMB insiders and whales buy or sell their stock.

CMMB Shareholders

What type of owners hold Chemomab Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Access Industries Holdings LLC1.20%6,911,166$10.85MInsider
Gabriel Capital Management Ltd0.87%5,034,150$7.90MInsider
Orbimed Israel GP Ltd0.39%2,241,274$3.52MInsider
George Adi Mor0.23%1,339,964$2.10MInsider
Peter Thiel0.15%877,973$1.38MInsider
Dennison T. Veru0.07%396,540$622.57kInsider
Citadel Advisors LLC0.02%103,781$162.94kInstitution
Adar1 Capital Management LLC0.01%80,000$125.60kInstitution
Ikarian Capital LLC0.01%51,793$81.32kInstitution
Kestra Private Wealth Services LLC0.01%51,710$81.18kInstitution

1 of 3

CMMB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CMMB0.06%2.94%
AEON5.32%94.68%Net Buying
JUNS1.86%32.80%Net Buying
SNGX0.42%99.58%Net Buying
ACXP4.85%90.09%

Chemomab Therapeutics Stock Ownership FAQ

Who owns Chemomab Therapeutics?

Chemomab Therapeutics (NASDAQ: CMMB) is owned by 0.06% institutional shareholders, 2.94% Chemomab Therapeutics insiders, and 97.00% retail investors. Access Industries Holdings LLC is the largest individual Chemomab Therapeutics shareholder, owning 6.91M shares representing 1.20% of the company. Access Industries Holdings LLC's Chemomab Therapeutics shares are currently valued at $10.99M.

If you're new to stock investing, here's how to buy Chemomab Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.